Ulcickas Yood M, Bortolini M, Casso D, Beck JG, Oliveria S, Wells KE, Woodcroft KJ and Wang LI.
Incidence of liver injury among cancer patients receiving chemotherapy in an integrated health system.
Pharmacoepidemiology and Drug Safety. 2015 Published online in Wiley Online Library (wileyonlinelibrary.com) DOI: 10.1002/pds.3757.
Johnson CC, Jankowski M, Rolnick S, Ulcickas Yood M, Alford SH.
Influence of NSAID Use Among Colorectal Cancer Survivors on Cancer Outcomes.
American Journal of Clinical Oncology. 2014 Dec 10. [Epub ahead of print]
McGlynn KA, Divine GW, Sahasrabuddhe VV, Engel LS, VanSlooten A, Wells K, Ulcickas Yood M, Alford SH.
Statin use and risk of hepatocellular carcinoma in a U.S. population.
Cancer Epidemiology. 2014 Oct;38(5):523-7. doi: 10.1016/j.canep.2014.06.009. Epub 2014 Aug 10.
Jordan JH, Thwin SS, Lash TL, Buist DS, Field TS, Haque R, Pawloski PA, Petersen HV, Prout MN, Quinn VP, Ulcickas Yood M, Silliman RA, Geiger AM.
Incident comorbidities and all-cause mortality among 5-year survivors of Stage I and II breast cancer diagnosed at age 65 or older: a prospective-matched cohort study.
Breast Cancer Research and Treatment. 2014 Jul;146(2):401-9. doi: 10.1007/s10549-014-3021-8. Epub 2014 Jun 18.
Yardley DA, Kaufman PA, Brufsky A, Ulcickas Yood M, Rugo H, Mayer M, Quah C, Yoo B, Tripathy D.
Treatment patterns and clinical outcomes for patients with de novo versus recurrent HER2-positive metastatic breast cancer.
Breast Cancer Research and Treatment. 2014 Jun;145(3):725-34. doi: 10.1007/s10549-014-2916-8. Epub 2014 Apr 6.
Tsai H, Keating NL, Van Den Eeden SK, Haque R, Cassidy-Bushrow AE, Ulcickas Yood M, Smith MR, Potosky AL
Risk of Diabetes among Patients Receiving Primary Androgen Deprivation Therapy for Clinically Localized Prostate Cancer.
The Journal of Urology. 2014 Dec 15. pii: S0022-5347(14)05079-4. doi: 10.1016/j.juro.2014.12.027. [Epub ahead of print]
Potosky AL, Haque R, Cassidy-Bushrow AE, Ulcickas Yood M, Jiang M, Tsai HT, Luta G, Keating NL, Smith MR, Van Den Eeden SK.
Effectiveness of primary androgen-deprivation therapy for clinically localized prostate cancer.
Journal of Clinical Oncology. 2014; March 17 [Epub ahead of print]
Lash TL, Thwin SS, Ulcickas Yood M, Geiger AM, Bosco J, Quinn VP, Field TS, Pawloski PA, Silliman RA.
Comprehensive evaluation of the incidence of late effects in 5-year survivors of breast cancer.
Breast Cancer Research and Treatment. 2014; Apr;144(3):643-63. doi: 10.1007/s10549-014-2885-y. Epub 2014 Mar 1.
Amiri L, Cassidy-Bushrow AE, Dakki H, Li J, Wells K, Oliveria SA, Ulcickas Yood M, Lanfear T.
Patient characteristics and participation in a genetic study: a type 2 diabetes cohort.
Journal of Investigative Medicine. 2014;62(1) 26-32.
Haque R, Prout M, Geiger AM, Kamineni A, Thwin SS, Avila C, Silliman RA, Quinn V, Ulcickas Yood M.
Comorbidities and cardiovascular disease risk in older breast cancer survivors.
American Journal of Managed Care. 2014;20(1):86-92.
Allen LA, Ulcickas Yood M, Wagner EH, Aiello Bowles EJ, Pardee R, Wellman R, Habel L, Nekhlyudov L, Davis RL, Onitilo AA, Magid DJ.
Performance of claims-based algorithms for identifying heart failure and cardiomyopathy among patients diagnosed with breast cancer. Pharmacovigilance Research Group.
Medical Care. 2014 May;52(5):e30-8.
Buist DSM, Bosco JLF, Silliman RA, Gold H, Field T, Ulcickas Yood M, Quinn VP, Prout M, Lash TL.
Survival benefit associated with long-term surveillance mammography in older women with a history of early stage invasive breast cancer.
Breast Cancer Research and Treatment. 2013;142(1):153-63.
Rugo HS, Brufsky AM, Ulcickas Yood M, Tripathy D, Kaufman PA, Mayer M, Yoo B, Abidoye O, Yardley DA.
Racial disparities in treatment patterns and clinical outcomes in patients with HER-2 positive metastatic breast cancer.
Breast Cancer Research and Treatment. 2013;141(3):461-70.
Tripathy D, Kaufman PA, Brufsky AM, Mayer M, Ulcickas Yood M, Yoo B, Quah C, Yardley D, Rugo HS.
First-Line Treatment Patterns and Clinical Outcomes in Patients With HER2-Positive and Hormone Receptor-Positive Metastatic Breast Cancer From registHER.
Bowles EJ, Wellman R, Feigelson HS, Onitilo AA, Freedman AN, Delate T, Allen LA, Nekhlyudov L, Goddard KA, Davis RL, Habel LA, Ulcickas Yood M, McCarty C, Magid DJ, Wagner EH; Pharmacovigilance Study Team.
Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study.
Journal of the National Cancer Institute. 2012;104 (17):1293-1305.
Kaufman PA, Brufsky AM, Mayer M, Rugo HS, Tripathy D, Ulcickas Yood M, Feng S, Wang LI, Quah CS, Yardley DA.
Treatment patterns and clinical outcomes in elderly patients with HER-2 positive metastatic breast cancer from the registHER observational study.
Breast Cancer Research and Treatment. 2012;135(3):875-83.
Chubak J, Yu O, Pocobelli G, Lamerato L, Webster J, Prout MN, Ulcickas Yood M, Barlow WE, Buist DS.
Administrative data algorithms to identify second breast cancer events following early-stage invasive breast cancer.
Journal of the National Cancer Institute. 2012;104(12):931-40. Epub 2012 Apr 30.
Ulcickas Yood M, Wells, KE, Hensley Alford S, Dakki H, Beiderbeck A, Hurria A, Gross CP, Oliveria SA.
Cardiovascular outcomes in women with advanced breast cancer exposed to chemotherapy.
Pharmacoepidemiology and Drug Safety. 2012;21(8):818-27.
Delate T, Aiello Bowles EJ, Pardee R, Wellman RD, Habel LA, Ulcickas Yood M, Nekhlyudov L, Goddard KA, Davis RL, McCarty CA, Onitilo AA, Spencer Feigelson H, Freml J, Wagner E.
Validity of eight integrated healthcare delivery organizations’ administrative clinical data to capture breast cancer chemotherapy exposure.
Cancer, Epidemiology, Biomarkers, and Prevention. 2012;21(4):637-80.
Ulcickas Yood M, Oliveria SA, Cziraky M, Hirji I, Hamdan M, Davis C.
Adherence to treatment with second-line therapies, dasatinib and nilotinib, in patients with chronic myeloid leukemia.
Curr Med Res Opin. 2012; 28(2):1-7.
Ulcickas Yood M, Delorenze GH, Quesenberry CP, Oliveria SA, Tsai A, Kim E, Cziraky MJ, McQuade R, Newcomer JW, L'Italien G.
Association between second-generation antipsychotics and newly diagnosed treated diabetes mellitus: does the effect differ by dose?
BMC Psychiatry 2011; 11(1):197.
Field TS, Bosco JLF, Prout MN, Gold HT, Cutrona S, Pawloski PA, Ulcickas Yood M, Quinn VP, Thwin SS, Silliman RA.
Age, comorbidity and breast cancer severity- their impact on receipt of definitive local therapy and rate of recurrence among older women with early stage breast cancer.
Journal of the American College of Surgeons 2011; 213(6):757-65. Epub 2011 Oct 19.
Haque R, Ulcickas Yood M, Geiger AM, Kamineni A, Avila CC, Shi J, Silliman RA, Quinn VP.
Long term safety of radiotherapy and breast cancer laterality in older survivors.
Cancer Epidemiology, Biomarkers and Prevention 2011; 20(10):2120-6.
Brufsky AM, Mayer M, Rugo HS, Kaufman PA, Tan-Chiu E, Tripathy D, Tudor IC, Wang LI, Brammer MG, Shing M, Ulcickas Yood M, Yardley DA.
Central nervous system metastases in patients with HER2-positive metastatic breast cancer: Incidence, treatment and survival in patients from registHER.
Clinical Cancer Research. 2011; 17(14):4834-43.
Davis RL, Eastman D, McPhillips H, Raebel MA, Andrade SE, Smith D, Ulcickas Yood M, Dublin S, Platt R.
Risks of congenital malformations and perinatal events among infants exposed to calcium channel and beta-blockers during pregnancy.
Pharmacoepidemiology and Drug Safety. 2011; 20(2):138-45.
Ulcickas Yood M, Delorenze G, Quesenberry CP Jr, Tsai AL, Phillips S, Willey VJ, Niemcryk SJ, Wells K, Skovron ML, Cziraky MJ, Carson W, Oliveria SA.
Epidemiologic study of aripiprazole use and the incidence of suicide events.
Pharmacoepidemiol Drug Saf. 2010 Nov;19(11):1124-30.
Donato BM, Burns L, Willey V, Cohenuram M, Oliveria S, Yood MU.
Treatment patterns in patients with advanced breast cancer who were exposed to an anthracycline, a taxane, and capecitabine: a descriptive report.
Clinical Therapeutics 2010 Mar;32(3):546-54.
Bosco JFL, Silliman RA, Thwin SS, Geiger AM, Buist DSM, Prout MN, Ulcickas Yood M, Haque R, Wei F, Lash TL.
A most stubborn bias: no adjustment method fully resolves confounding by indication in observational studies.
Journal of Clinical Epidemiology. 2010 Jan;63(1):64-74. Epub 2009 May 19.
Mapel DW, Schum M, Ulcickas Yood M, Brown J, Miller DP, Davis KJ.
Pneumonia among COPD patients using inhaled corticosteroids and long-acting bronchodilators.
Primary Care Respiratory Journal. 2010 Jan 15. [Epub ahead of print].
Ulcickas Yood M, Delorenze GH, Quesenberry CP, L'Italien G, Oliveria SA, Willey VJ, Tsai A, McQuade R, Newcomer JW.
The incidence of diabetes in atypical antipsychotic users differs according to agent---Results from a multisite epidemiologic study.
Pharmacoepidemiology and Drug Safety. 2009 Sep;18(9):791-9.
Kozloff M, Ulcickas Yood M, Flynn PJ, Berlin J, Kabbinavar FF, Sargent D, Purdie DM, Dong W, Sugrue MM, Grothey A.
Clinical outcomes associated with bevacizumab-containing treatment of metastatic colorectal cancer: The BRiTE observational cohort study.
The Oncologist. 2009 Sep;14(9):862-70. Epub 2009 Sep 2.
Gold HT, Thwin SS, Buist DSM, Field TS, Wei F, Ulcickas Yood M, Quinn V, Lash TL, Geiger AM, Silliman RA.
Radiotherapy delay in older women with early stage breast cancer in integrated healthcare delivery systems.
American Journal of Managed Care. 2009;15:785-789.
Ahern TP, Bosco JLF, Silliman RA, Ulcickas Yood M, Field TS, Wei F, Lash TL.
Potential misinterpretations caused by collapsing upper categories of comorbidity indices: an illustration from a cohort of older breast cancer survivors.
Clinical Epidemiology. 2009;1:93-100.
Lafata JE, Dobie EA, Divine GW, Ulcickas Yood M, McCarthy BD.
Sustained hyperglycemia among patients with diabetes: what matters when action is needed?
Diabetes Care. 2009;32(8):1447-52.
Buist DSM, Chubak J, Prout M, Ulcickas Yood M Bosco JLF, Thwin SS, Gold HT, Owusu C, Field TS, Quinn VP, Wei F, Silliman RA.
Referral, receipt and completion of chemotherapy in early stage breast cancer patients aged 65 and older at high-risk of breast cancer recurrence.
Journal of Clinical Oncology. 2009 Sep 20;27(27):4508-14. Epub 2009 Aug 17.
Ulcickas Yood M, Oliveria SA, Campbell UB, Koro KE.
Incidence of cancer in a population-based cohort of patients with Type 2 diabetes.
Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2009;3:12-16.
Goff SL, Feld A, Andrade SE, Mahoney L, Beaton SJ, Boudreau DM, Davis RL, Goodman M, Hartsfield CL, Platt R, Roblin D, Smith D, Yood MU, Dodd K, Gurwitz JH.
Administrative data used to identify patients with irritable bowel syndrome.
Journal of Clinical Epidemiology. 2008 Jun;61(6):617-21. Epub 2008 Mar 4.
Oliveria SA, Koro CE, Ulcickas Yood M, Sowell M.
Cancer incidence among patients treated with antidiabetic pharmacotherapy.
Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2008;2:47-57.
Field TS, Doubeni C, Fox MP, Buist DSM, Wei F, Geiger AM, Quinn VP, Lash TL, Prout MN, Ulcickas Yood M, Frost FJ, Silliman RA.
Under utilization of surveillance mammography among older breast cancer survivors.
Journal of General Internal Medicine 2007 Dec 1; [Epub ahead of print]
Oliveria SA, Menditto LA, Ulcickas Yood M, Koo YH, Wells KE, McCarthy BD.
Barriers to initiation of and persistence with insulin therapy.
Current Medical Research and Opinion 2007;23:3105-12.
Stang PE, Frank C, Ulcickas Yood M, Wells K, Burch S.
Impact of Bipolar Disorder: Results from a screening study.
Journal of Clinical Psychiatry Primary Care Companion 2007;9:42-47.
Ulcickas Yood M, Owusu C, Buist DSM, Geiger AM, Field TS, Thwin SS, Lash TL, Prout MN, Wei F, Quinn VP, Frost FJ, Silliman RA.
Mortality impact of less than standard therapy in older breast cancer patients.
Journal of the American College of Surgeons 2008;206:66-75. Epub 2007 Oct 3.
Ulcickas Yood, M, Campbell UB, Rothman KJ, Jick SS, Lang J, Wells KE, Jick H, Johnson CC.
Using prescription claims data for drugs available over the counter (OTC).
Pharmacoepidemiology and Drug Safety 2007;16:961-8.
Fortuny J, Johnson C, Bohlke K, Chow W-H, Hart G, Kucera G, Mujumdar U, Ownby D, Wells K, Ulcickas Yood M, Engel LS.
Use of anti-inflammatory drugs and lower esophageal sphincter relaxing drugs and risk of esophageal and gastric cancers.
Clinical Gastroenterology and Hepatology 2007;5:1154-1159. Epub 2007 Jul 23.
Davis RL, Rubanowice D, McPhillips H, Raebel MA, Andrade SE, Smith D, Ulcickas Yood M, Platt R.
Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy.
Pharmacoepidemiology and Drug Safety 2007;16:1086-94.
Owusu C, Buist DSM, Field TS, Lash TL, Thwin SS, Geiger AM, Quinn VP, Frost F, Prout M, Ulcickas Yood M, Wei F, Silliman RA.
Predictors of tamoxifen discontinuation among older women with estrogen-receptor positive breast cancer.
Journal of Clinical Oncology 2008;26:549-55. Epub 2007 Dec 10.
Buist DSM, Ichikawa L, Prout MN, Ulcickas Yood M, Field T, Owusu C, Geiger AM, Quinn VP, Wei F, Silliman RA.
Receipt of primary breast cancer therapy and adjuvant therapy are not associated with obesity in older women treated in integrated health plans.
Journal of Clinical Oncology 2007; 25:3428-3436.
Lash TL, Fox MP, Buist DSM, Wei F, Field TS, Frost FJ, Quinn VP, Ulcickas Yood M, Silliman RA.
Mammography Surveillance and Mortality in Older Breast Cancer Survivors.
Journal of Clinical Oncology 2007;25:3001-6. Epub 2007 Jun 4.
Ulcickas Yood M, Quesenberry CP, Guo D, Wells K, Shan J, Sanders L, Skovron M, Iloeje U, Caldwell C, Manos MM.
Incidence of hepatocellular carcinoma among individuals with Hepatitis B Virus infection identified using an automated data algorithm.
Journal of Viral Hepatitis 2008;15:28-36. Epub 2007 Sep 24.
Lash TL, Fox MP, Thwin SS, Geiger A, Buist DSM, Wei F, Field TS, Ulcickas Yood M, Frost FJ, Enger SM, Prout MN, Silliman RA.
Using probabilistic corrections to account for abstractor agreement in medical record reviews.
American Journal of Epidemiology 2007;165:1454-61. Epub 2007 Apr 3.
Mapel DW, Nelson LS, Lydic E, Soriano J, Ulcickas Yood M, Davis K.
Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone.
Journal of Chronic Obstructive Pulmonary Disease 2007;4:127-134.
Ulcickas Yood M, Quesenberry CP, Guo D, Caldwell C, Wells K, Shan J, Sanders L, Skovron M, Iloeje U, Manos MM.
Incidence of non-Hodgkin's lymphoma among individuals with chronic Hepatitis B virus infection.
Hepatology2007;46:107-12. Epub 2007 May 24.
Geiger AM, Thwin SS, Lash TL, Buist DSM, Prout M, Wei F, Field TS, Ulcickas Yood M, Frost FJ, Enger SM, Silliman RA.
Recurrences and second primary breast cancers in older women with initial early-stage disease.
Stang P, Morris L, Kempf J, Henderson S, Ulcickas Yood M, Oliveria S.
The co-prescription of contraindicated drugs with statins: continuing potential for increased risk of adverse events.
American Journal of Therapeutics 2007;14:30-40.
Elston Lafata J, Simpkins J, Kaatz S, Horn JR, Raebel MA, Schultz L, Smith DH, Ulcickas Yood M.
What do medical records tell us about potentially harmful co-prescribing?
Joint Commission Journal on Quality and Patient Safety 2007;33:395-400.
Arellano FM, Ulcickas Yood M, Wentworth CE, Oliveria S, Rothman KJ.
Use of cyclo-oxygenase-2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAID) in a UK and a USA population: Implications for COX-2 cardiovascular profile.
Pharmacoepidemiology and Drug Safety 2006;15:861-872.
Ulcickas Yood M, Elston Lafata J, Koro C, Wells KE, Pladevall M.
Time to pharmacotherapy change in response to elevated HbA1c Test Results.
Current Medical Research and Opinion 2006;22:1567-1574.
Enger SM, Thwin SS, Buist DS, Field T, Frost F, Geiger AM, Lash TL, Prout M, Ulcickas Yood M, Wei F, Silliman RA.
Breast cancer treatment among older women in integrated health care settings.
Journal of Clinical Oncology 2006;24:4377-4383.
Stang PE, Krishnan A, Frank C, Ulcickas Yood M, Wells K.
The clinical history and costs associated with delayed diagnosis of bipolar disorder.
Medscape General Medicine 2006;8(2):18.
Ulcickas Yood M, McCarthy BD, Kempf J, Kucera G, Wells K, Oliveria S, Stang P.
Racial differences in reaching target low density lipoprotein goal among individuals treated with prescription statin therapy.
American Heart Journal 2006;152:777-84.
Andrade SE, Raebel MA, Morse AN, Davis RL, Chan KA, Finkelstein JA, Fortman K, McPhillips H, Roblin D, Smith DH, Ulcickas Yood M, Platt R, Gurwitz JH.
Use of prescription medications with a potential for fetal harm among pregnant women.
Pharmacoepidemiology and Drug Safety 2006;15:546-54.
Doubeni C, Field T, Ulcickas Yood M, Rolnick S, Quesenberry CP, Fouayzi H, Gurwitz J, Wei FX.
Patterns and predictors of mammography utilization among breast cancer survivors.
Stang PE, Frank C, Ulcickas Yood M, Wells K, Burch S, Muma B.
Bipolar disorder detection, ascertainment, and treatment: Primary care physician knowledge, attitudes and awareness.
Primary Care Companion to the Journal of Clinical Psychiatry 2006; 8:147-152.
Ulcickas Yood M, Watkins E, Wells K, Kucera G, Johnson CC, Lydick E.
The impact of NSAID or COX-2 inhibitor use on the initiation of antihypertensive therapy.
Pharmacoepidemiology and Drug Safety 2006;15:852-860.
Elston Lafata J, Schultz L, Simpkins J, Chan KA, Horn JR, Kaatz S, Long C, Platt R, Raebel MA, Smith DH, Xi H, Ulcickas Yood M.
Potential drug-drug interactions in the outpatient setting.
Medical Care 2006;44:534-41.
Cooper GS, Johnsosn CC, Lamerato L, Poisson LM, Schultz L, Simpkins J, Wells K, Ulcickas Yood M, Chase G, Nathanson D, Elston Lafata J.
Use of guideline recommended follow up care in cancer survivors: routine or diagnostic indications?
Medical Care 2006; 44:590-4.
Ulcickas Yood M, Quesenberry CP, Alford SH, Tsai A, Wells KE, Yood SM, Ackermann Shiff SP.
An observational study examining the impact of capecitabine on warfarin antithrombotic activity and bleeding complications.
Current Medical Research and Opinion 2006;22:307-314.
Rolnick S, Kucera GP, Hensley Alford S, Fortman K, Ulcickas Yood M, Jankowski M, Johnson CC.
Racial and age differences in colon examination surveillance following a diagnosis of colorectal cancer.
Journal of the National Cancer Institute Monographs 2005;35:96-101.
Mouchawar J, Taplin S, Ichikawa L, Barlow WE, Geiger A, Weinmann S, Gilbert J, Manos M, Ulcickas Yood M.
Late-stage breast cancer among women with recent negative screening mammography: do clinical encounters offer opportunity for earlier detection?
Journal of the National Cancer Institute Monographs 2005;35:39-46.
Weinmann S, Taplin S, Gilbert J, Beverly K, Geiger A, Ulcickas Yood M, Mouchawar J, Manos MM, Zapka J, Westbrook E, Barlow W.
Characteristics of women refusing follow-up for tests or symptoms suggestive of breast cancer.
Journal of the National Cancer Institute Monographs 2005;35:33-38.
Zapka JG, Puleo E, Taplin S, Solber LI, Mouchawar J, Somkin C, Geiger A, Ulcickas Yood M.
Breast and cervical cancer screening: Clinicians views on health plan guidelines and implementation efforts.
Journal of the National Cancer Institute Monographs 2005;35:46-54.
Puleo E, Zapka JG, Valentine Goins K, Ulcickas Yood M, Taplin S, Mouchawar J, Manos M, Somkin C.
Recommendations for care related to follow-up of abnormal cancer screening tests: accuracy of patient report.
Evaluation and the Health Professions 2005;28:310-27.
Taplin SH, Barlow WE, Ulcickas Yood M, Westbrook E, Geiger AM, Bischoff K, Ichikawa L.
Re: Breast cancer comes full circle. Response (letter).
Journal of the National Cancer Institute 2005;97:461.
Leyden WA, Manos MM, Geiger AM, Weinmann S, Taplin SH, Mouchawar J, Bischoff K, Ulcickas Yood M, Gilbert J.
Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
Journal of the National Cancer Institute 2005;97:675-83.
Elston Lafata J, Simpkins J, Shultz L, Chase GA, Johnson CC, Ulcickas Yood M, Lamerato L, Nathanson D, Cooper G.
Routine surveillance care after cancer treatment with curative intent.
Medical Care 2005;43:592-9.
Taplin S, Ulcickas Yood M, Geiger A, Ichikawa L, Bischoff K, Barlow W.
Re: Reason for late-stage breast cancer: absence of screening or detection or breakdown in follow-up? Response (letter).
Journal of the National Cancer Institute 2004;97:400-401.
Taplin SH, Ichikawa L, Ulcickas Yood M, Manos MM, Geiger A, Weinman S, Gilbert J, Mouchawar J, Leyden W, Altaras R, Beverly K, Casso D, Westbrook E, Zapka J, Barlow WE.
Reasons for late-stage breast cancer among women with access to care: absence of screening, absence of detection or potential breakdown in followup?
Journal of the National Cancer Institute 2004;96:1518-27.
Andrade SE, Gurwitz JH, Davis RL, Chan KA, Finkelstein JA, Fortman K, McPhillips H, Raebel MA, Roblin D, Smith DH, Ulcickas Yood M, Morse AN, Platt R.
Prescription drug use in pregnancy.
American Journal of Obstetrics and Gynecology 2004;191:398-407.
Zapka JG, Puleo E, Taplin S, Valentine Goins K, Ulcickas Yood M, Mouchawar J, Somkin C, Manos M.
Processes of care in cervical and breast cancer screening and follow-up-- The importance of communication.
Preventive Medicine 2004;39:81-90.
Oliveria SA, Ulcickas Yood M, Cambell UB, Yood SM, Stang P.
Treatment and referral patterns for colorectal cancer.
Medical Care 2004;42:901-906.
Valentine Goins K, Zapka JG, Geiger AM, Solberg LI, Taplin S, Ulcickas Yood M, Gilbert J, Mouchawar J, Somkin C, Weinmann S.
Implementation of systems strategies for breast and cervical cancer screening services in health maintenance organizations.
American Journal of Managed Care 2003;9:745-755.
Ulcickas Yood M, Oliveria S, Boyer JG, Wells K, Stang P, Johnson CC.
Colon polyp recurrence in a managed care population.
Archives of Internal Medicine 2003;163:422-426.
Delea TE, Vera-Llonch M, Edelsberg JS, McGarry L, Anton S, Ulcickas Yood M, Oster G.
The incidence and cost of hospitalization for 5-FU toxicity among Medicare beneficiaries with metastatic colorectal cancer.
Value in Health 2002;5:35-43.
Platt R, Davis R, Finkelstein J, Go A, Gurwitz J, Roblin D, Soumerai S, Ross-Degnan D, Andrade S, Goodman M, Martinson B, Raebel M, Smith D, Ulcickas Yood M, Chan A.
Multicenter epidemiologic and health services research on therapeutics in the HMO Research Network Center for Education and Research on Therapeutics.
Pharmacoepidemiology and Drug Safety 2001; 10:373-377.
Ulcickas Yood M, Johnson CC, Blount A, Abrams J, Wolman E, McCarthy BD, Raju U, Nathanson DS, Worsham M, Wolman SR.
Race and differences in breast cancer survival in a managed care population.
Journal of the National Cancer Institute 1999;91:1487-1491.
Ulcickas Yood M, McCarthy BD, Lee NC, Jacobsen G., Johnson CC.
Patterns and Characteristics of Repeat Mammography Among Women 50 Years and Older.
Cancer Epidemiology, Biomarkers and Prevention 1999;8:595-599.
Velanovich V, Ulcickas Yood M, Bawle U, Nathanson SD, Strand VF, Talpos GB, Szymanski W, Lewis FR.
Racial differences in the presentation and surgical management of breast cancer.
Baker AM, McCarthy BD, Gurley VF, Ulcickas Yood M.
Influenza immunization in a managed care organization.
Journal of General Internal Medicine 1998;7:469-475.
McCarthy BD, Ulcickas Yood M, Bolton M, Boohaker EA, MacWilliam CH, Young MJ.
Redesigning primary care processes to improve the offering of mammography. The use of clinic protocols by non-physicians.
Journal of General Internal Medicine 1997;12:357-363.
MacWilliam CH, Ulcickas Yood M, Verner J, McCarthy BD, Ward RE.
Patient related risk factors which predict poor outcome after total hip replacement.
Health Services Research 1996;31:623-38.
McCarthy BD, Ulcickas Yood M, Boohaker EA, Ward RE, Rebner M, Johnson CC.
Inadequate follow-up of abnormal mammograms.
American Journal of Preventive Medicine 1996;12:282-8.
McCarthy BD, Ulcickas Yood M, Janz NK, Boohaker EA, Ward RE, Johnson CC.
Evaluation of factors potentially associated with inadequate follow-up of mammographic abnormalities.
McCarthy BD, Ulcickas M, Wilcock CH, Lee M.
Screening mammography use: the importance of a population perspective.
American Journal of Preventive Medicine 1996;12:91-5.
Copeland M, Senkowski C, Ulcickas M, Mendelsohn M, Griepp R.
Breast size as a risk factor for sternal wound complications following cardiac surgery.
Archives of Surgery 1994;129:757-759.
Berman I, Ulcickas M, Yood SM, Grant RL.
Cancer trends unique to Georgia.
Journal of the Medical Association of Georgia.1993;82:29-33.
Milunsky A, Morris S, Jick H, Rothman KJ, Ulcickas M, Jick SS, Shoukimas P, Willet W.
Maternal zinc and fetal neural tube defects.
Jick H, Ulcickas M.
Comparison of frequencies of suicidal tendencies among patients receiving fluoxetine, lofepramine, mianserin or trazodone.
Milunsky A, Ulcickas M, Rothman KJ, Willett W, Jick SS, Jick H.
Maternal heat exposure and neural tube defects.
Shulman S, Dicerbo P, Ulcickas M.
A survey of therapeutic substitution programs in ten Boston area hospitals.
Drug Information Journal 1992;26:41-52.
The Orphan Drug Act: A discussion of issues surrounding the legislation and its implementation.
Drug News and Perspectives 1990;3:307-308.
Richard B, Ulcickas M.
Approvable letters in the FDA new drug approval process.
Journal of Clinical Pharmacology 1989;29:680-684.
Wastila L, Ulcickas M, Lasagna L.
The World Health Organization's essential drug list: the significance of "me-too" and follow-on research.
Journal of Clinical Research and Drug Development 1989;3:105-115.
Shulman S, Ulcickas M.
Update on ADR reporting regulations: products liability implications.
Journal of Clinical Research and Drug Development 1989;3:91-103.